Login

Crafting Your Financial Future | Smith Bruer Advisors 00:10:00

Share On Facebook Share On Twitter

Rene Bruner is the CFP and Advisor of smith bruer advisors

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
David Marsh Chief Executive Officer, Surgical Innovations Group
00:10:00
The Benefits of Opening a Roth IRA for Your Child | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Summary of Ameri100 S/4HANA | Maria Wei, Managing Partner/CEO, Ameri Holdings Inc AMRH:NAQ
00:10:00
Strategic Growth and Financial Resilience: Insights from BNP Paribas CFO Lars Machenil
00:10:00
AI Interfaces and the Future of MLOps with Tristan Zajonc | Tristan Zajonc, CEO , Continual Ltd.
00:10:00
Roger McNamee Discusses Netflix's Position Amidst Streaming Competition and Regulatory Challenges |Roger McNamee, Co-Founder, Elevation Partners.
00:10:00
How Should We Treat the Bad Guys?|Jenny Martinez
00:10:00
This is how a successful IT career began in Salzburg | Peter Belly, Managing Director, B+S Banksysteme AGDTD2X:GER
00:10:00
Industry Insights with Michael Piershale | President of Piershale Financial Group
00:10:00
Embracing Disruption and Human Connection in Business Leadership | Mary Powell, CEO ,Sunrun Inc.
00:10:00
Ulrika Jonsson on Strategic Growth and SaaS Innovation at Brilliant Future | Ulrika Jonsson, CEO, Brilliant Future AB.
00:10:00
The Squeeze on Startups: How VC Funding Decline Could Stifle Innovation|Amy Cheetham,Partner,Costanoa Ventures

© 2026 Nehu